AI formulation scientist for accelerated development
The AI Formulation Scientist is an end-to-end AI solution that automates formulation development, significantly reducing time and costs. It replicates cognitive tasks of scientists, analyzes data swiftly, and is highly adaptable for industry needs, with a TRL of 9.
Overview
The AI Formulation Scientist is an innovative AI platform designed to accelerate the formulation development process across industries, notably pharmaceuticals and nutraceuticals. Developed by Ceuvita, it replicates the cognitive and computational tasks traditionally executed by formulation scientists, significantly cutting down the time and cost involved in developing new formulations. The platform is user-friendly, requiring no coding skills, and is accessible via a web browser. It is capable of rapidly reading scientific literature, generating hypotheses, planning experiments, and analyzing characterization data, which can save millions in R&D costs as demonstrated in past projects.
Technical specifications
The AI Formulation Scientist can accomplish several tasks with remarkable efficiency:
- Literature Review: Reads and synthesizes scientific, patent, and clinical trial literature in under 5 minutes.
- Data Analysis: Analyzes thermal, spectroscopy, and other characterization data in under 10 minutes.
- Formulation Development: Proposes working formulations and suggests alternative compounds based on physicochemical properties.
- Experimental Protocols: Writes detailed experimental protocols and conducts risk assessments.
- Integration: Interfaces with hardware like electronic tongues and ingests standard operating procedures (SOPs).
- Customization: Platform customization to meet specific organizational needs, including mobile app development.
Technology readiness level
The AI Formulation Scientist is at Technology Readiness Level 9, indicating it is fully operational and has been validated in real-world settings. Past projects have shown its capability to reduce development pipelines from 12-18 months to just 4 months, proving its efficacy and readiness for commercial deployment.
About Queen Mary University of London
Queen Mary University of London is a comprehensive public research university within the University of London, serving a large and diverse community across campuses in East and Central London. Integration with a major NHS hospital network provides co‑located clinical and translational facilities and access to trial infrastructure and real‑world datasets. An on‑site innovation ecosystem with wet‑lab and startup space, plus proximity to the City and Tech City, connects researchers to London’s finance and digital industry clusters. Research is supported by competitive funding from UK Research and Innovation councils, the National Institute for Health and Care Research, and leading UK charities. A dedicated technology transfer company manages IP, licensing, consultancy, spinouts, and Knowledge Transfer Partnerships to streamline collaboration.
delivered to your inbox.